Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Protein tyrosine kinase inhibitors from Warner-Lambert

Dec. 31, 1996

Beiersdorf-Lilly claims angiotensin II blockers

Dec. 30, 1996

Hyal products for restenosis receive U.S. patent coverage

Dec. 24, 1996

Intercardia and Knoll reach agreement for CHF drug

Dec. 24, 1996

Genzyme commences cardiovascular gene therapy collaboration

Dec. 20, 1996

Dual NEP/ACE inhibitors claimed by Eisai

Dec. 20, 1996

Therapeutically active nicotinic acid esters described by Scotia

Dec. 19, 1996

Biovail grants another license for diltiazem product

Dec. 18, 1996

Beta-blocker treatment reduces fatal post-surgical heart attack

Dec. 18, 1996

Method for treatment of CPVD available for licensing

Dec. 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...